Christopher Berger, MD
Assistant Professor
Medicine
School of Medicine

He works with Dr. Adithya Cattamanchi on projects in the Philippines to improve the diagnostic and clinical tools used in MDR and XDR TB and in Uganda designing improved versions of the globally utilized “Directly Observed Therapy” toolkit. Christopher completed his undergraduate degree in international health at the University of Pittsburgh where he went on complete his MD. He received his master’s in tropical medicine and international health at the Universitat Autonoma de Barcelona in Barcelona, Spain. He completed his internal medicine residency and pulmonary/critical care medicine fellowship at UCSF. He is currently completing a masters in Clinical Research at UCSF.

• Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
  PLoS medicine 2021 Semitala FC, Kadota JL, Musinguzi A, Nabunje J, Welishe F, Nakitende A, Akello L, Bishop O, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PPJ, Katahoire A, Berger CA, Kiwanuka…
• Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.
  Implementation science communications 2021 Semitala FC, Musinguzi A, Ssemata J, Welishe F, Nabunje J, Kadota JL, Berger CA, Katamba A, Kiwanuka N, Kamya MR, Dowdy D, Cattamanchi A, Katahoire AR
• Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
  PLoS medicine 2021 Cattamanchi A, Crowder R, Kityamuwesi A, Kiwanuka N, Lamunu M, Namale C, Tinka LK, Nakate AS, Ggita J, Turimumahoro P, Babirye D, Oyuku D, Berger C, Tucker A, Patel D, Sammann A, Turyahabwe S, Dowdy D…
• Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods.
  JMIR formative research 2020 Patel D, Berger CA, Kityamuwesi A, Ggita J, Kunihira Tinka L, Turimumahoro P, Feler J, Chehab L, Chen AZ, Gupta N, Turyahabwe S, Katamba A, Cattamanchi A, Sammann A
• Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
  BMJ open 2020 Crowder R, Kityamuwesi A, Kiwanuka N, Lamunu M, Namale C, Tinka LK, Nakate AS, Ggita J, Turimumahoro P, Babirye D, Oyuku D, Berger CA, Tucker A, Patel D, Sammann A, Dowdy D, Stavia T, Cattamanchi A, …
• Opportunities to improve digital adherence technologies and TB care using human-centered design.
  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2020 Berger C, Patel D, Kityamuwesi A, Ggita J, Tinka LK, Turimumahoro P, Neville K, Chehab L, Chen AZ, Gupta N, Turyahabwe S, Katamba A, Cattamanchi A, Sammann A
• Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda.
  Journal of clinical tuberculosis and other mycobacterial diseases 2020 Berger CA, Kityamuwesi A, Crowder R, Lamunu M, Kunihira Tinka L, Ggita J, Sanyu Nakate A, Namale C, Oyuku D, Chen K, Turyahabwe S, Cattamanchi A, Katamba A
• Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.
  Implementation science : IS 2020 Kadota JL, Musinguzi A, Nabunje J, Welishe F, Ssemata JL, Bishop O, Berger CA, Patel D, Sammann A, Katahoire A, Nahid P, Belknap R, Phillips PPJ, Namusobya J, Kamya M, Handley MA, Kiwanuka N, Katamba …
• Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis.
  Annals of the American Thoracic Society 2020 Berger CA, Alipanah N, Kheir F, Ruminjo JK, Nahid P, Thomson C
• Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy.
  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2020 Kadota JL, Katamba A, Musinguzi A, Welishe F, Nabunje J, Ssemata JL, Berger CA, Kamya MR, Namusobya J, Semitala FC, Cattamanchi A, Dowdy DW
• Management and Outcomes of Critically-III Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series.
  medRxiv : the preprint server for health sciences 2020 Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, …
• Presentation and outcome of suspected sepsis in a high-HIV burden, high antiretroviral coverage setting.
  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 Chaka W, Berger C, Huo S, Robertson V, Tachiona C, Magwenzi M, Magombei T, Mpamhanga C, Katzenstein D, Metcalfe J
• Implementation science to improve the quality of tuberculosis diagnostic services in Uganda.
  Journal of clinical tuberculosis and other mycobacterial diseases 2019 Cattamanchi A, Berger CA, Shete PB, Turyahabwe S, Joloba M, Moore DA, Davis LJ, Katamba A
• Open-source point-of-care electronic medical records for use in resource-limited settings: systematic review and questionnaire surveys.
  BMJ open 2012 Millard PS, Bru J, Berger CA